THE EFFECT OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ON WORK PARTICIPATION IN LONGSTANDING RHEUMATOID ARTHRITIS: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

被引：1
|
作者：
Alunno, A. [1 ]
Marques, M. L. [2 ,3 ]
Falzon, L. [4 ]
Ramiro, S. [2 ,5 ]
Boonen, A. [6 ]
机构：
[1] Univ LAquila, Dept Life Hlth & Environm Sci, Internal Med & Nephrol Unit, Laquila, Italy
[2] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[3] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal
[4] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England
[5] Zuyderland Med Ctr, Dept Rheumatol, Herleen, Netherlands
[6] Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.3562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0364
引用
收藏
页码：1309 / 1309
页数：1
相关论文
共 50 条
  • [1] Are Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs Associated with Work Participation Improvement in Early Rheumatoid Arthritis? A Systematic Review and Meta-analysis
    Marques, Mary Lucy
    Alunno, Alessia
    Falzon, Louise
    Boonen, Annelies
    Ramiro, Sofi A.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1669 - 1671
  • [2] ARE BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ASSOCIATED WITH WORK PARTICIPATION IMPROVEMENT IN EARLY RHEUMATOID ARTHRITIS? A SYSTEMATIC REVIEW AND META-ANALYSIS
    Marques, M. L.
    Alunno, A.
    Falzon, L.
    Boonen, A.
    Ramiro, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 522 - 523
  • [3] USE OF BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND THE RISK OF LYMPHOMA IN RHEUMATOID ARTHRITIS
    Singh, N.
    Peterson, A.
    Baraff, A.
    Bhatti, P.
    Gopal, A.
    Smith, N.
    Barton, J.
    Curtis, J.
    Li, C.
    Weiss, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1060 - 1061
  • [4] Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Gopal, Ajay
    Smith, Nicholas
    Barton, Jennifer
    Curtis, Jeffrey
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2381 - 2382
  • [5] Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cancer in Rheumatoid Arthritis
    Sendaydiego, Xavier
    Gold, Laura
    Liew, Jean
    Wysham, K.
    Dubreuil, Maureen
    Andrews, James
    Reid, Pankti
    Liew, David
    Goulabchand, Radjiv
    Singh, Abha
    Hughes, Grant
    Pioro, Mathilde
    Sparks, Jeffrey
    Jarvik, Jeffrey
    Singh, Siddharth
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3333 - 3336
  • [6] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
  • [7] Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review
    Combe, Bernard
    Durez, Patrick
    Boone, Caroline
    Lula, Sadiq
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 658 - 667
  • [8] Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cardiovascular Outcomes in Rheumatoid Arthritis
    Sendaydiego, Xavier
    Gold, Laura
    Wysham, K.
    Liew, Jean
    Dubreuil, Maureen
    Andrews, James
    Reid, Pankti
    Liew, David
    Goulabchand, Radjiv
    Singh, Abha
    Hughes, Grant
    Pioro, Mathilde
    Sparks, Jeffrey
    Jarvik, Jeffrey
    Singh, Siddharth
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 848 - 850
  • [9] Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study
    Tada, Masahiro
    Matsumoto, Yoshinari
    Koike, Tatsuya
    Mamoto, Kenji
    Nakamura, Tomoyuki
    Anno, Shohei
    Iida, Takahiro
    Goto, Hitoshi
    Hidaka, Noriaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (10)
  • [10] Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
    Choy, Ernest H.
    RHEUMATOLOGY, 2019, 58 : 51 - 55
12345